7.2. Level of disclosure required for medical use – credible effect
  1. Home
  2. Legal texts
  3. Case Law of the Boards of Appeal
  4. Case Law of the Boards of Appeal of the European Patent Office
  5. II. Patent application and amendments
  6. C. Sufficiency of disclosure
  7. 7. The requirement of sufficiency of disclosure in the biotechnology field
  8. 7.2. Level of disclosure required for medical use
  9. 7.2.3 Evidence of therapeutic effect
  10. d) Whether opponents can cite post-published documents
Print
Facebook Twitter Linkedin Email

7.2.3 Evidence of therapeutic effect

Overview

d) Whether opponents can cite post-published documents

See, in this chapter II.C.7.4., the decision T 1872/16, in which the board stated that opponents were free to use whatever evidence they chose to substantiate their serious doubts. This also applied to the date on which the evidence was generated.

Previous
Next
Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility